StockGlow

FENNEC PHARMACEUTICALS INC (FRX.TO)

Sells a drug that protects children's hearing during cancer treatment.

13.95-0.05%Healthcare
Compare FRX.TO with
StockGlow Score
89
Bullish
BearishBullish
1 year ago+26.7%

The outlook

FRX.TO is trading at $13.95, positioned in the upper portion of its 52-week range. The stock sits above both its 50- and 200-day moving averages, reflecting strength in its recent trend. Analyst sentiment skews bullish overall, though specific coverage details aren't provided here.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range81% of the way from its 52-week low to high
Market cap
—
52-wk high
15.48
52-wk low
7.59
50-day avg
13.91
200-day avg
11.38
Trailing P/E
—

Similar stocks

HBP.TOHelix BioPharma Corp.$1.45+0.69%MDNA.TOMedicenna Therapeutics Corp.$0.36+2.90%EDT.TOSpectral Medical Inc.$1.37-0.72%PRN.TOProfound Medical Corp.$10.27-1.63%RVX.TOResverlogix Corp.$0.10-4.76%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy